Moreover, genistein-mediated suppression of mTOR increases dephosphorylation and the subsequent nuclear translocation of TFEB, which is associated with a significant increase in lysosomal content and activity in treated cancer and non-cancerous cells. The gene discussed is MTOR; the disease is cancer.